These emerging treatments, Tirzepatide , represent a groundbreaking advancement in treating type 2 diabetes and possibly associated conditions . They all are grouped as GLP-1 pathway agonists , meaning they function to emulate the endogenous GLP-1 substance , stimulating metabolic production and lowering hunger . While Tirzepatide every functions r